Lack of Visibility Across Supply Chain Biggest Concern, say Top Pharmaceutical Companies

MUMBAI, August 27, 2012 /PRNewswire/ --

"The greatest concern today in supply chain within the pharmaceutical industry is the lack of visibility across the transportation chain especially for air shipments," says Thomas Lobo, Director Global External Supply Asia-India Region, Pfizer Pharmaceuticals. 

He continues, "Though there is the availability of track and trace technology to enable the industry to gain better control over the supply chain, however, high cost, difficulty of implementation, lack of industry standards and uniform regulatory guidelines pose hurdles in implementing such technology. In today's scenario, where the Indian pharmaceutical industry is in the middle of unprecedented growth, these challenges are impediments to its growth."

Jigish Chiniwala, Director, Condot Systems, adds, "Anti-counterfeiting is a big issue not only in international markets but also in India. To make anti-counterfeiting more effective, the industry needs to purchase UID numbers from the government and display them on primary, secondary and tertiary packaging with human readable characters and that can be verified by any telephone operator."

Both Thomas and Jigish will be sharing their views at the Pharma Supply Chain Management conference taking place from 17-19 October at The Westin Mumbai Garden City, India.

Over 200 industry experts will be gathering including leading companies such as Glenmark Pharmaceuticals, Ranbaxy, Biocon, Dr. Reddy's, Pfizer, Roche Diagnostics, Novartis Pharma, Jubilant Life Sciences, Zydus Cadila and Watson Pharmaceuticals.

Sponsors include Zebra Technologies, Sproxil, PharmaSecure, Condot Systems, Cargo Service Centre and MIBS.

Issues being addressed at the conference include regulatory landscape, role of supply chain professional, quality and security of supply chain, counterfeiting and bar-coding, partnership opportunities, cold chain management, managing airport logistics, and replenishment issues.

Ryan Viegas, Vice President, Supply Chain and Procurement, Watson Pharma, who has been attending the conference for the past two years says, "The Pharma Supply Chain event is an annual event valued by pharma professionals."

In addition to networking with industry peers, the event provides opportunities to benchmark supply chain and logistics best practices as well as keep updated on recent developments in India and the region.

Please visit www.pharmasupplychainindia.com/pr for more details.

About CPhI India

CPhI India is a UBM brand, and is the largest and most important meeting place for the Indian pharma industry. Each year CPhI attracts around 850 exhibitors and 30,000 visitors to the show, providing us with an unrivalled reach to all the key decision makers in the Indian Pharma industry.

About UBM

UBM is a global live media and B2B communications, marketing service and data provider founded in 1918. We help organisations make connections, communicate their proposition and do business effectively. We enable professional people in more than 40 countries around the world to connect and engage with each other, with the markets they serve and with the information they need to succeed. And we do this by whatever means works best - at live events, through digital media or in publications. Company size: 6000-6500 employees. Website: http://www.ubm.com/.

Primary Media Contact: Asan Bano, conferences-india@ubm.com, 91-22-40461466

SOURCE UBM India Pvt. Ltd.